Separately, IL-10–STAT3 signaling upregulates the m6A reader YTHDF2 in tumor-associated macrophages, and restraining YTHDF2 reprograms macrophages toward an IFN-high, antigen-supportive state and restores CD8+ T-cell activity. Here, CD8A is linked to neoplasm.